Kiora Pharmaceuticals, Inc. (KPRX:NASDAQ) closed at $1.44 on November 6, 2026, down 4.00% on the day. The stock trades 50.5% below its 52-week high of $2.91 and 2.9% above its 52-week low of $1.40. Over the past year, it lost 38.2%. Kiora Pharmaceuticals, Inc. is part of the Health Care sector.
In 252 trading sessions since November 6, 2025, KPRX closed higher on 105 days (42%). Its best day was April 8, 2026 (+32.41%) and its worst was October 29, 2026 (-25.42%). The stock moved 10% or more in a single session 6 times. It opened at least 5% above the previous day's high 2 times.
Kiora Pharmaceuticals Inc is a clinical-stage specialty pharmaceutical company. It focuses on developing and commercializing products for treating diseases and disorders of the eye. The products pipeline of the company includes KIO-101, KIO-201, KIO-301, and KIO-102.
Find more stocks like KPRX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.